These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16507965)

  • 21. Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients.
    Compton MT; Kelley ME; Ramsay CE; Pringle M; Goulding SM; Esterberg ML; Stewart T; Walker EF
    Am J Psychiatry; 2009 Nov; 166(11):1251-7. PubMed ID: 19797432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder.
    Ringen PA; Nesvåg R; Helle S; Lagerberg TV; Lange EH; Løberg EM; Agartz I; Andreassen OA; Melle I
    Psychol Med; 2016 Nov; 46(15):3127-3136. PubMed ID: 27534999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabis and development of dual diagnoses: A literature review.
    Hanna RC; Perez JM; Ghose S
    Am J Drug Alcohol Abuse; 2017 Jul; 43(4):442-455. PubMed ID: 27612527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marijuana use in the immediate 5-year premorbid period is associated with increased risk of onset of schizophrenia and related psychotic disorders.
    Kelley ME; Wan CR; Broussard B; Crisafio A; Cristofaro S; Johnson S; Reed TA; Amar P; Kaslow NJ; Walker EF; Compton MT
    Schizophr Res; 2016 Mar; 171(1-3):62-7. PubMed ID: 26785806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia.
    Leeson VC; Harrison I; Ron MA; Barnes TR; Joyce EM
    Schizophr Bull; 2012 Jun; 38(4):873-80. PubMed ID: 21389110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia.
    Sevy S; Robinson DG; Napolitano B; Patel RC; Gunduz-Bruce H; Miller R; McCormack J; Lorell BS; Kane J
    Schizophr Res; 2010 Jul; 120(1-3):101-7. PubMed ID: 20471224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lifetime history of substance misuse in first-episode psychosis: prevalence and its influence on psychopathology and onset of psychotic symptoms.
    Kamali M; McTigue O; Whitty P; Gervin M; Clarke M; Browne S; Larkin C; O'Callaghan E
    Early Interv Psychiatry; 2009 Aug; 3(3):198-203. PubMed ID: 22640383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abuse or dependence on cannabis and other psychiatric disorders. Madrid study on dual pathology prevalence.
    Arias F; Szerman N; Vega P; Mesias B; Basurte I; Morant C; Ochoa E; Poyo F; Babin F
    Actas Esp Psiquiatr; 2013; 41(2):122-9. PubMed ID: 23592072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabis use is associated with 3years earlier onset of schizophrenia spectrum disorder in a naturalistic, multi-site sample (N=1119).
    Helle S; Ringen PA; Melle I; Larsen TK; Gjestad R; Johnsen E; Lagerberg TV; Andreassen OA; Kroken RA; Joa I; Ten Velden Hegelstad W; Løberg EM
    Schizophr Res; 2016 Jan; 170(1):217-21. PubMed ID: 26682958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association between cannabis use and earlier age at onset of schizophrenia and other psychoses: meta-analysis of possible confounding factors.
    Myles N; Newall H; Nielssen O; Large M
    Curr Pharm Des; 2012; 18(32):5055-69. PubMed ID: 22716150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis.
    Dragt S; Nieman DH; Schultze-Lutter F; van der Meer F; Becker H; de Haan L; Dingemans PM; Birchwood M; Patterson P; Salokangas RK; Heinimaa M; Heinz A; Juckel G; Graf von Reventlow H; French P; Stevens H; Ruhrmann S; Klosterkötter J; Linszen DH;
    Acta Psychiatr Scand; 2012 Jan; 125(1):45-53. PubMed ID: 21883099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of a first episode of psychosis in adolescence: a 2-year follow-up.
    Pencer A; Addington J; Addington D
    Psychiatry Res; 2005 Jan; 133(1):35-43. PubMed ID: 15698675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substance use and common child mental health problems: examining longitudinal associations in a British sample.
    Goodman A
    Addiction; 2010 Aug; 105(8):1484-96. PubMed ID: 20528814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis.
    Boydell J; Dean K; Dutta R; Giouroukou E; Fearon P; Murray R
    Schizophr Res; 2007 Jul; 93(1-3):203-10. PubMed ID: 17462864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Legal substance use and the development of a DSM-IV cannabis use disorder during adolescence: the TRAILS study.
    Prince van Leeuwen A; Creemers HE; Verhulst FC; Vollebergh WA; Ormel J; van Oort F; Huizink AC
    Addiction; 2014 Feb; 109(2):303-11. PubMed ID: 24033662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
    Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
    Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbid substance use disorders in schizophrenia: a latent class approach.
    Kerner B
    Psychiatry Res; 2015 Feb; 225(3):395-401. PubMed ID: 25576367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurocognitive function and schizophrenia-proneness in individuals dependent on ketamine, on high potency cannabis ('skunk') or on cocaine.
    Morgan CJ; Duffin S; Hunt S; Monaghan L; Mason O; Curran HV
    Pharmacopsychiatry; 2012 Nov; 45(7):269-74. PubMed ID: 22511328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues.
    Coulston CM; Perdices M; Tennant CC
    Aust N Z J Psychiatry; 2007 Nov; 41(11):869-84. PubMed ID: 17924240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does accumulating exposure to illicit drugs bring forward the age at onset in schizophrenia?
    Power BD; Dragovic M; Jablensky A; Stefanis NC
    Aust N Z J Psychiatry; 2013 Jan; 47(1):51-8. PubMed ID: 23042939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.